IHMC hosts Fredric G. Levin Lung Care Symposium March 27-28 in Pensacola

The Fredric G. Levin Lung Care Symposium will bring to Pensacola experts in thoracic surgery, lung cancer research, and pulmonary care for a day of groundbreaking discussions and advancements in the field.

Hosted on the campus of the Florida Institute for Human and Machine Cognition (IHMC), this live virtual and in-person symposium serves as a platform for physicians, researchers, and healthcare professionals to explore the latest innovations in lung cancer treatment, surgical techniques, and patient care strategies.

“IHMC takes seriously our place as a home for innovation and scientific collaboration,” said Dr. Morley Stone, IHMC’s Chief Executive Officer. “Working with the team at Brigham and Women’s Hospital to host the Levin Lung Symposium is our honor.”

Established through the generosity of Pensacola native Fredric G. Levin, this symposium reflects his commitment to advancing medical research and improving patient outcomes. Levin was a highly regarded plaintiff’s attorney with a national reputation whose career spanned more than 40 years. He died in 2021 of COVID after having survived stage 4 lung and brain cancer.

Sessions will feature renowned faculty, emerging research, and multidisciplinary collaboration to drive progress in thoracic surgery and lung health.

As a leader in lung cancer treatment and thoracic surgery, the Brigham and Women’s Hospital Division of Thoracic Surgery is honored to host this event, reinforcing its mission to deliver cutting-edge care and transformative research.

The symposium is a unique resource for physicians, nurses, advanced practice providers, researchers, trainees, and medical students. Agenda highlights include:

• Surgical Innovation: Unveiling the latest techniques and breakthroughs in lung cancer surgery.
• Lung Cancer Diagnosis and Screening: Exploring innovative methods for early detection.
• Resources for Lung Cancer Screening: Equipping you with the essential tools for effective screening.
• Lung Cancer Screening Programs: A deep dive into program development and best practices.
• The Importance of Multidisciplinary Collaboration: Fostering teamwork for comprehensive patient care.
• Challenges in Coordinating Multidisciplinary Care: Navigating the complexities of collaboration.
• Clinical Pathways and Collaboration: Streamlining patient journeys for optimal outcomes.
• Palliative Care: Enhancing the quality of life for lung cancer patients.
• Medical Risk and Error: Strategies for minimizing risk and maximizing patient safety.

The registration link is here: https://cmecatalog.hms.harvard.edu/fredric-g-levin-lung-cancer-symposium . Use the discount code FGLLCSMEDSTU25 at checkout for a $25 registration fee.

IHMC is a not-for-profit research institute of the Florida University System where researchers pioneer science and technology aimed at leveraging and extending human capabilities. IHMC researchers and staff collaborate extensively with the government, industry and academia to help develop breakthrough technologies. IHMC research partners have included: DARPA, the National Science Foundation, NASA, Army, Navy, Air Force, National Institutes of Health, IBM, Microsoft, Honda, Boeing, Lockheed, and many others.